Cover Image
市場調查報告書

JW Pharmaceutical Corporation:產品平台分析

JW Pharmaceutical Corporation - Product Pipeline Review - 2016

出版商 Global Markets Direct 商品編碼 257852
出版日期 內容資訊 英文 39 Pages
訂單完成後即時交付
價格
Back to Top
JW Pharmaceutical Corporation:產品平台分析 JW Pharmaceutical Corporation - Product Pipeline Review - 2016
出版日期: 2016年09月30日 內容資訊: 英文 39 Pages
簡介

JW Pharmaceutical Corporation是提供學名藥的製藥公司,從事止痛藥,退燒藥,感冒藥,解毒劑,抗菌劑,抗癌藥等產品之開發,製造及銷售。該公司也提供綜合維他命和抗貧血藥物,隱形眼鏡保養和眼科用劑,抗真菌藥物,心血管促效劑,腸胃藥等產品。其他各種藥物產品也齊備。

本報告提供JW Pharmaceutical Corporation 的治療藥開發平台現狀及各開發階段比較分析,提供您藥物標的,作用機制,給藥途徑,各分子類型的治療藥的評估,中止的計劃等相關資訊。

JW Pharmaceutical Corporation的基本資料

  • JW Pharmaceutical Corporation概要
  • 主要資訊
  • 企業資料

JW Pharmaceutical Corporation:R&D概要

  • 主要的治療範圍

JW Pharmaceutical Corporation:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品
  • 聯合治療模式
  • 合作夥伴產品
    • 合作夥伴產品/聯合治療模式

JW Pharmaceutical Corporation:開發中產品概況

  • 最後階段的開發中產品
    • 第三期的產品/聯合治療模式
  • 臨床實驗階段的開發中產品
    • 第二期的產品/聯合治療模式
    • 第一期的產品/聯合治療模式
  • 初期階段的開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

JW Pharmaceutical Corporation:藥物簡介

JW Pharmaceutical Corporation:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

JW Pharmaceutical Corporation:最近的開發平台趨勢

JW Pharmaceutical Corporation:暫停中的計劃

JW Pharmaceutical Corporation:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC08141CDB

Summary

Global Markets Direct's, 'JW Pharmaceutical Corporation - Product Pipeline Review - 2016', provides an overview of the JW Pharmaceutical Corporation's pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by JW Pharmaceutical Corporation, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data.

Scope

  • The report provides a snapshot of the pipeline therapeutic landscape of JW Pharmaceutical Corporation
  • The report provides overview of JW Pharmaceutical Corporation including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses JW Pharmaceutical Corporation's pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features JW Pharmaceutical Corporation's out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects

Reasons to buy

  • Evaluate JW Pharmaceutical Corporation's strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for JW Pharmaceutical Corporation
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it's most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding JW Pharmaceutical Corporation's pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • JW Pharmaceutical Corporation Snapshot
    • JW Pharmaceutical Corporation Overview
    • Key Facts
  • JW Pharmaceutical Corporation - Research and Development Overview
    • Key Therapeutic Areas
  • JW Pharmaceutical Corporation - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
    • Pipeline Products - Combination Treatment Modalities
    • Pipeline Products - Partnered Products
      • Partnered Products/Combination Treatment Modalities
  • JW Pharmaceutical Corporation - Pipeline Products Glance
    • JW Pharmaceutical Corporation - Late Stage Pipeline Products
      • Phase III Products/Combination Treatment Modalities
    • JW Pharmaceutical Corporation - Clinical Stage Pipeline Products
      • Phase I Products/Combination Treatment Modalities
    • JW Pharmaceutical Corporation - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • JW Pharmaceutical Corporation - Drug Profiles
    • (pitavastatin + valsartan) - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CW-108F - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWF-0701 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWF-0771 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWF-07pre03 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWF-0808 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWF-09pre02 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWP-232228 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • CWP-291 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • docetaxel - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • JWF-1103 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
    • JWF-1201 - Drug Profile
      • Product Description
      • Mechanism Of Action
      • R&D Progress
  • JW Pharmaceutical Corporation - Pipeline Analysis
    • JW Pharmaceutical Corporation - Pipeline Products by Target
    • JW Pharmaceutical Corporation - Pipeline Products by Route of Administration
    • JW Pharmaceutical Corporation - Pipeline Products by Molecule Type
    • JW Pharmaceutical Corporation - Pipeline Products by Mechanism of Action
  • JW Pharmaceutical Corporation - Dormant Projects
  • JW Pharmaceutical Corporation - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • JW Pharmaceutical Corporation, Key Facts
  • JW Pharmaceutical Corporation - Pipeline by Indication, 2016
  • JW Pharmaceutical Corporation - Pipeline by Stage of Development, 2016
  • JW Pharmaceutical Corporation - Monotherapy Products in Pipeline, 2016
  • JW Pharmaceutical Corporation - Combination Treatment Modalities in Pipeline, 2016
  • JW Pharmaceutical Corporation - Partnered Products in Pipeline, 2016
  • JW Pharmaceutical Corporation - Partnered Products/ Combination Treatment Modalities, 2016
  • JW Pharmaceutical Corporation - Phase III, 2016
  • JW Pharmaceutical Corporation - Phase I, 2016
  • JW Pharmaceutical Corporation - Preclinical, 2016
  • JW Pharmaceutical Corporation - Discovery, 2016
  • JW Pharmaceutical Corporation - Pipeline by Target, 2016
  • JW Pharmaceutical Corporation - Pipeline by Route of Administration, 2016
  • JW Pharmaceutical Corporation - Pipeline by Molecule Type, 2016
  • JW Pharmaceutical Corporation - Pipeline Products by Mechanism of Action, 2016
  • JW Pharmaceutical Corporation - Dormant Developmental Projects,2016

List of Figures

  • JW Pharmaceutical Corporation - Pipeline by Top 10 Indication, 2016
  • JW Pharmaceutical Corporation - Pipeline by Stage of Development, 2016
  • JW Pharmaceutical Corporation - Monotherapy Products in Pipeline, 2016
  • JW Pharmaceutical Corporation - Partnered Products in Pipeline, 2016
  • JW Pharmaceutical Corporation - Pipeline by Top 10 Target, 2016
  • JW Pharmaceutical Corporation - Pipeline by Route of Administration, 2016
  • JW Pharmaceutical Corporation - Pipeline by Molecule Type, 2016
  • JW Pharmaceutical Corporation - Pipeline Products by Top 10 Mechanism of Action, 2016
Back to Top